10-Q 1 pl-20240731.htm 10-Q pl-20240731
0001836833FALSE2025Q2--01-310.2xbrli:sharesiso4217:USDiso4217:USDxbrli:sharespl:segmentxbrli:purepl:providerpl:tranchepl:tradingDay00018368332024-02-012024-07-310001836833us-gaap:CommonClassAMember2024-02-012024-07-310001836833us-gaap:WarrantMember2024-02-012024-07-310001836833us-gaap:CommonClassAMember2024-09-030001836833us-gaap:CommonClassBMember2024-09-0300018368332024-07-3100018368332024-01-310001836833us-gaap:CommonClassAMember2024-07-310001836833us-gaap:CommonClassAMember2024-01-310001836833us-gaap:CommonClassBMember2024-01-310001836833us-gaap:CommonClassBMember2024-07-310001836833us-gaap:CommonClassCMember2024-07-310001836833us-gaap:CommonClassCMember2024-01-3100018368332024-05-012024-07-3100018368332023-05-012023-07-3100018368332023-02-012023-07-310001836833us-gaap:CommonStockMember2023-01-310001836833us-gaap:AdditionalPaidInCapitalMember2023-01-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-310001836833us-gaap:RetainedEarningsMember2023-01-3100018368332023-01-310001836833us-gaap:CommonStockMember2023-02-012023-04-300001836833us-gaap:AdditionalPaidInCapitalMember2023-02-012023-04-3000018368332023-02-012023-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-02-012023-04-300001836833us-gaap:RetainedEarningsMember2023-02-012023-04-300001836833us-gaap:CommonStockMember2023-04-300001836833us-gaap:AdditionalPaidInCapitalMember2023-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-300001836833us-gaap:RetainedEarningsMember2023-04-3000018368332023-04-300001836833us-gaap:CommonStockMember2023-05-012023-07-310001836833us-gaap:AdditionalPaidInCapitalMember2023-05-012023-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-05-012023-07-310001836833us-gaap:RetainedEarningsMember2023-05-012023-07-310001836833us-gaap:CommonStockMember2023-07-310001836833us-gaap:AdditionalPaidInCapitalMember2023-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-310001836833us-gaap:RetainedEarningsMember2023-07-3100018368332023-07-310001836833us-gaap:CommonStockMember2024-01-310001836833us-gaap:AdditionalPaidInCapitalMember2024-01-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-310001836833us-gaap:RetainedEarningsMember2024-01-310001836833us-gaap:CommonStockMember2024-02-012024-04-300001836833us-gaap:AdditionalPaidInCapitalMember2024-02-012024-04-3000018368332024-02-012024-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-012024-04-300001836833us-gaap:RetainedEarningsMember2024-02-012024-04-300001836833us-gaap:CommonStockMember2024-04-300001836833us-gaap:AdditionalPaidInCapitalMember2024-04-300001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-300001836833us-gaap:RetainedEarningsMember2024-04-3000018368332024-04-300001836833us-gaap:CommonStockMember2024-05-012024-07-310001836833us-gaap:AdditionalPaidInCapitalMember2024-05-012024-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-012024-07-310001836833us-gaap:RetainedEarningsMember2024-05-012024-07-310001836833us-gaap:CommonStockMember2024-07-310001836833us-gaap:AdditionalPaidInCapitalMember2024-07-310001836833us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-310001836833us-gaap:RetainedEarningsMember2024-07-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-02-012024-07-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-05-012024-07-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2024-02-012024-07-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-05-012023-07-310001836833pl:Customer1Memberus-gaap:CustomerConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerMember2023-02-012023-07-3100018368332024-08-012024-07-310001836833country:US2024-05-012024-07-310001836833country:US2023-05-012023-07-310001836833country:US2024-02-012024-07-310001836833country:US2023-02-012023-07-310001836833us-gaap:NonUsMember2024-05-012024-07-310001836833us-gaap:NonUsMember2023-05-012023-07-310001836833us-gaap:NonUsMember2024-02-012024-07-310001836833us-gaap:NonUsMember2023-02-012023-07-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-07-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-07-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-07-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-07-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-07-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-07-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-07-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-07-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-07-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-07-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-07-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-07-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-07-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2024-01-310001836833us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPublicMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-01-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:MeasurementInputPriceVolatilityMember2024-07-310001836833pl:WarrantsPrivatePlacementMemberus-gaap:MeasurementInputPriceVolatilityMember2024-01-310001836833pl:SaloSciencesMemberus-gaap:MeasurementInputExpectedTermMember2024-07-310001836833pl:WarrantsPrivatePlacementMember2023-01-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-01-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-01-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-01-310001836833pl:WarrantsPrivatePlacementMember2023-02-012023-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-02-012023-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-02-012023-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-02-012023-04-300001836833pl:WarrantsPrivatePlacementMember2023-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-04-300001836833pl:WarrantsPrivatePlacementMember2023-05-012023-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-05-012023-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-05-012023-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-05-012023-07-310001836833pl:WarrantsPrivatePlacementMember2023-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2023-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2023-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2023-07-310001836833pl:WarrantsPrivatePlacementMember2024-01-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-01-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-01-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-01-310001836833pl:WarrantsPrivatePlacementMember2024-02-012024-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-02-012024-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-02-012024-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-02-012024-04-300001836833pl:WarrantsPrivatePlacementMember2024-04-300001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-04-300001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-04-300001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-04-300001836833pl:WarrantsPrivatePlacementMember2024-05-012024-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-05-012024-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-05-012024-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-05-012024-07-310001836833pl:WarrantsPrivatePlacementMember2024-07-310001836833pl:TechnicalMilestoneContingentConsiderationLiabilityMember2024-07-310001836833pl:CustomerContractEarnoutContingentConsiderationMember2024-07-310001836833pl:CustomerConsentEscrowContingentConsiderationMember2024-07-310001836833pl:SinergiseMember2024-01-310001836833pl:SinergiseMember2024-07-310001836833us-gaap:MoneyMarketFundsMember2024-07-310001836833us-gaap:MoneyMarketFundsMember2024-01-310001836833us-gaap:USTreasurySecuritiesMember2024-07-310001836833us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-07-310001836833us-gaap:CorporateBondSecuritiesMember2024-07-310001836833us-gaap:CertificatesOfDepositMember2024-07-310001836833us-gaap:USTreasurySecuritiesMember2024-01-310001836833us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2024-01-310001836833us-gaap:CorporateBondSecuritiesMember2024-01-310001836833us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-01-310001836833us-gaap:CertificatesOfDepositMember2024-01-310001836833pl:SatellitesMember2024-07-310001836833pl:SatellitesMember2024-01-310001836833pl:SatellitesInProcessAndNotPlacedIntoServiceMember2024-07-310001836833pl:SatellitesInProcessAndNotPlacedIntoServiceMember2024-01-310001836833us-gaap:LeaseholdImprovementsMember2024-07-310001836833us-gaap:LeaseholdImprovementsMember2024-01-310001836833pl:GroundStationAndGroundStationEquipmentMember2024-07-310001836833pl:GroundStationAndGroundStationEquipmentMember2024-01-310001836833us-gaap:FurnitureAndFixturesMember2024-07-310001836833us-gaap:FurnitureAndFixturesMember2024-01-310001836833pl:ComputerEquipmentAndSoftwareMember2024-07-310001836833pl:ComputerEquipmentAndSoftwareMember2024-01-310001836833country:US2024-07-310001836833country:US2024-01-310001836833us-gaap:NonUsMember2024-07-310001836833us-gaap:NonUsMember2024-01-310001836833pl:SatellitesMember2024-05-012024-07-310001836833pl:SatellitesMember2024-02-012024-07-310001836833pl:SatellitesMember2023-05-012023-07-310001836833pl:SatellitesMember2023-02-012023-07-310001836833us-gaap:DevelopedTechnologyRightsMember2024-07-310001836833us-gaap:DevelopedTechnologyRightsMember2024-02-012024-07-310001836833us-gaap:DevelopedTechnologyRightsMember2024-01-310001836833us-gaap:DevelopedTechnologyRightsMember2023-02-012024-01-310001836833us-gaap:AcquiredFilmLibrariesMember2024-07-310001836833us-gaap:AcquiredFilmLibrariesMember2024-02-012024-07-310001836833us-gaap:AcquiredFilmLibrariesMember2024-01-310001836833us-gaap:AcquiredFilmLibrariesMember2023-02-012024-01-310001836833us-gaap:CustomerRelationshipsMember2024-07-310001836833us-gaap:CustomerRelationshipsMember2024-02-012024-07-310001836833us-gaap:CustomerRelationshipsMember2024-01-310001836833us-gaap:CustomerRelationshipsMember2023-02-012024-01-310001836833us-gaap:TrademarksAndTradeNamesMember2024-07-310001836833us-gaap:TrademarksAndTradeNamesMember2024-02-012024-07-310001836833us-gaap:TrademarksAndTradeNamesMember2024-01-310001836833us-gaap:TrademarksAndTradeNamesMember2023-02-012024-01-3100018368332023-02-012024-01-3100018368332024-06-012024-06-300001836833us-gaap:EmployeeSeveranceMember2024-05-012024-07-310001836833us-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2024-05-012024-07-310001836833us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:EmployeeSeveranceMember2024-05-012024-07-310001836833us-gaap:SellingAndMarketingExpenseMemberus-gaap:EmployeeSeveranceMember2024-05-012024-07-310001836833us-gaap:GeneralAndAdministrativeExpenseMemberus-gaap:EmployeeSeveranceMember2024-05-012024-07-310001836833pl:RDServicesAgreementMember2020-12-310001836833pl:RDServicesAgreementMember2024-05-012024-07-310001836833pl:RDServicesAgreementMember2024-02-012024-07-310001836833pl:RDServicesAgreementMember2023-05-012023-07-310001836833pl:RDServicesAgreementMember2023-02-012023-07-310001836833pl:RDServicesAgreementMember2023-02-012024-01-3100018368332022-08-012022-08-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2022-08-012022-08-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2024-05-012024-07-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2024-02-012024-07-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-05-012023-07-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-02-012023-07-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-02-012024-01-310001836833pl:NationalAeronauticsSpaceAdministrationCommunicationServicesProjectMember2023-07-012023-07-310001836833pl:DMYIVLLCMember2021-03-092021-03-090001836833us-gaap:CommonClassAMemberpl:DMYIVLLCMember2021-03-090001836833pl:RedeemableWarrantMemberpl:DMYIVLLCMember2021-03-090001836833pl:WarrantsPublicMemberus-gaap:CommonClassAMember2021-03-090001836833pl:WarrantsPrivatePlacementMemberpl:DMYIVLLCMember2021-03-090001836833pl:WarrantsPrivatePlacementMember2021-12-0700018368332021-12-070001836833pl:DerivativeInstrumentPeriod1Member2021-12-070001836833pl:DerivativeInstrumentPeriod2Member2021-12-070001836833pl:DerivativeInstrumentPeriod3Member2021-12-070001836833pl:DerivativeInstrumentPeriod4Member2021-12-0700018368332021-12-072021-12-070001836833pl:WarrantsPublicMember2024-01-310001836833pl:WarrantsPublicMember2024-07-310001836833pl:WarrantsPrivatePlacementVestingMember2024-07-310001836833pl:WarrantsPrivatePlacementVestingMember2024-01-310001836833pl:A2020ConvertibleNotesMemberus-gaap:SeriesDPreferredStockMember2024-01-310001836833pl:A2020ConvertibleNotesMemberus-gaap:SeriesDPreferredStockMember2024-07-310001836833pl:A2020ConvertibleNotesMemberus-gaap:ConvertibleDebtMemberus-gaap:SeriesDPreferredStockMember2024-07-310001836833pl:A2020ConvertibleNotesMemberus-gaap:ConvertibleDebtMemberus-gaap:SeriesDPreferredStockMember2024-01-310001836833pl:A2020ConvertibleNotesMember2024-07-310001836833pl:PlanetLabsPBCMemberpl:GoogleMemberus-gaap:CommonClassAMember2024-07-310001836833pl:PlanetLabsPBCMemberpl:GoogleMemberus-gaap:CommonClassAMember2024-01-310001836833pl:PlanetLabsPBCMemberpl:GoogleMember2024-07-310001836833pl:PlanetLabsPBCMemberpl:GoogleMember2024-01-310001836833pl:GoogleMember2017-04-012017-04-300001836833pl:GoogleMemberpl:ContentLicensingMember2023-02-012023-07-310001836833pl:GoogleMember2023-07-012023-07-310001836833pl:GoogleMember2024-07-310001836833pl:GoogleMembersrt:MaximumMember2024-07-310001836833pl:GoogleMemberus-gaap:SubsequentEventMember2024-08-310001836833pl:GoogleMember2024-02-012024-07-310001836833pl:GoogleMember2023-02-012023-07-310001836833pl:GoogleMember2023-05-012023-07-310001836833pl:GoogleMember2024-07-310001836833pl:GoogleMember2024-01-310001836833pl:GoogleMemberpl:HostingAndOtherServicesMember2024-05-012024-07-310001836833us-gaap:RelatedPartyMember2024-05-012024-07-310001836833pl:GoogleMemberpl:HostingAndOtherServicesMember2024-02-012024-07-310001836833us-gaap:RelatedPartyMember2024-02-012024-07-310001836833pl:GoogleMemberpl:HostingAndOtherServicesMember2023-05-012023-07-310001836833us-gaap:RelatedPartyMember2023-05-012023-07-310001836833pl:GoogleMemberpl:HostingAndOtherServicesMember2023-02-012023-07-310001836833us-gaap:RelatedPartyMember2023-02-012023-07-310001836833pl:GoogleMember2021-06-280001836833us-gaap:CostOfSalesMember2024-05-012024-07-310001836833us-gaap:CostOfSalesMember2023-05-012023-07-310001836833us-gaap:CostOfSalesMember2024-02-012024-07-310001836833us-gaap:CostOfSalesMember2023-02-012023-07-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2024-05-012024-07-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2023-05-012023-07-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2024-02-012024-07-310001836833us-gaap:ResearchAndDevelopmentExpenseMember2023-02-012023-07-310001836833us-gaap:SellingAndMarketingExpenseMember2024-05-012024-07-310001836833us-gaap:SellingAndMarketingExpenseMember2023-05-012023-07-310001836833us-gaap:SellingAndMarketingExpenseMember2024-02-012024-07-310001836833us-gaap:SellingAndMarketingExpenseMember2023-02-012023-07-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2024-05-012024-07-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2023-05-012023-07-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2024-02-012024-07-310001836833us-gaap:GeneralAndAdministrativeExpenseMember2023-02-012023-07-3100018368332022-02-012023-01-310001836833us-gaap:EmployeeStockOptionMember2024-02-012024-07-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-01-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-02-012024-07-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-07-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-05-012024-07-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-05-012023-07-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-02-012023-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-02-012024-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMembersrt:MinimumMember2024-02-012024-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMembersrt:MaximumMember2024-02-012024-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-05-012024-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-02-012023-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-05-012023-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-07-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-04-012024-04-300001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-05-012024-07-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-02-012024-07-310001836833us-gaap:EmployeeStockMemberpl:A2024EmployeeStockPurchaseProgramMember2024-07-310001836833pl:EarnOutSharesMember2024-02-012024-07-310001836833pl:EarnOutSharesMember2024-05-012024-07-310001836833pl:EarnOutSharesMember2024-07-310001836833pl:EarnOutSharesMember2023-05-012023-07-310001836833pl:EarnOutSharesMember2023-02-012023-07-310001836833pl:VanderSatBVMemberus-gaap:StockCompensationPlanMemberus-gaap:CommonClassAMember2021-12-132021-12-130001836833pl:VanderSatBVMember2021-12-132021-12-130001836833pl:VanderSatBVMember2023-05-012023-07-310001836833pl:VanderSatBVMember2023-02-012023-07-310001836833pl:WarrantsClassACommonStockMember2024-02-012024-07-310001836833pl:WarrantsClassACommonStockMember2023-02-012023-07-310001836833us-gaap:EmployeeStockOptionMember2024-02-012024-07-310001836833us-gaap:EmployeeStockOptionMember2023-02-012023-07-310001836833us-gaap:RestrictedStockUnitsRSUMember2024-02-012024-07-310001836833us-gaap:RestrictedStockUnitsRSUMember2023-02-012023-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2024-02-012024-07-310001836833pl:PerformanceVestingRestrictedStockUnitsPSUsMember2023-02-012023-07-310001836833us-gaap:EmployeeStockMember2024-02-012024-07-310001836833us-gaap:EmployeeStockMember2023-02-012023-07-310001836833pl:EarnOutSharesMember2024-02-012024-07-310001836833pl:EarnOutSharesMember2023-02-012023-07-310001836833pl:SponsorEarnOutSharesMember2024-02-012024-07-310001836833pl:SponsorEarnOutSharesMember2023-02-012023-07-310001836833pl:WarrantsPublicMember2024-02-012024-07-310001836833pl:WarrantsPublicMember2023-02-012023-07-310001836833pl:WarrantsPrivatePlacementMember2024-02-012024-07-310001836833pl:WarrantsPrivatePlacementMember2023-02-012023-07-310001836833pl:StockOptionsEarlyExercisedSubjectToFutureVestingMember2024-02-012024-07-310001836833pl:StockOptionsEarlyExercisedSubjectToFutureVestingMember2023-02-012023-07-310001836833pl:SharesIssuedInAcquisitionSubjectToFutureVestingMember2024-02-012024-07-310001836833pl:SharesIssuedInAcquisitionSubjectToFutureVestingMember2023-02-012023-07-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 31, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________  to _______________.
Commission file number 001-40166
Planet Labs PBC
(Exact name of registrant as specified in its charter)
Delaware
85-4299396
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
645 Harrison Street, Floor 4, San Francisco, California
 94107
(Address of principal executive offices)
(Zip Code)
(415) 829-3313
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, par value $0.0001 per sharePLNew York Stock Exchange
Warrants to purchase Class A common stock, at an exercise price of $11.50 per sharePL WSNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes  ☒    No  ☐ 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒   No  ☐ 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer
Accelerated filer
Non-accelerated filer  
Smaller reporting company
Emerging growth company
                
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

1

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No  

The registrant had 272,318,817 outstanding shares of Class A common stock, and 21,157,586 outstanding shares of Class B common stock, as of September 3, 2024.

2

TABLE OF CONTENTS
Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
3


Unless the context otherwise requires, the “Company”, “Planet”, “we”, “our”, “us” and similar terms refer to Planet Labs PBC, a Delaware public benefit corporation (f/k/a dMY Technology Group, Inc. IV, a Delaware corporation), and its consolidated subsidiaries.

Cautionary Note Regarding Forward Looking Information

This Quarterly Report on Form 10-Q for the quarter ended July 31, 2024 (the “Form 10-Q” or “this report”) includes statements that express Planet’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements.” Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “seek,” “may,” “will,” “could,” “can,” “should,” “would,” “believes,” “predicts,” “potential,” “strategy,” “opportunity,” “aim,” “continue,” and similar expressions or the negative thereof, or discussions of strategy, plans, objectives, intentions, estimates, forecasts, outlook, assumptions, or goals, are intended to identify such forward-looking statements. Forward-looking statements appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the markets in which Planet operates. Factors that may impact such forward-looking statements include:
our future financial performance, including expectations regarding our revenue, cost of revenue, operating expenses, capital expenditures, cash flows and our ability to achieve profitability;
our ability to attract and retain customers, including our ability to renew existing contracts and expand our relationships with existing customers;
our expectations regarding the value of our offerings to our customers over time;
our expectations regarding market growth, including our ability to grow in existing markets and expand into new markets;
our ability to continue to improve our data and offer software and analytic solutions to improve the value of our data;
our ability to continue to invest in our sales and marketing, software platform development, machine learning and analytic tools as well as our applications and new satellite technologies;
our relationships with third-party partners, vendors and solution providers;
our ability to manage risks and challenges associated with our financial condition and results of operations;
our expectations regarding the future impact of seasonality on our business;
our management of future growth and business operations, as well as the expected results of our workforce reduction;
our expectations regarding the realization of our U.S. and foreign deferred tax assets;
our ability to maintain, protect and enhance our intellectual property; and
the increased expenses associated with being a public company.
The foregoing list may not contain all of the forward-looking statements made in this Form 10-Q. Such forward-looking statements are based on available current market material and our current expectations, beliefs and forecasts concerning future events and their potential effects on Planet. The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties, and other factors, including those described in the “Risk Factors” section of our most recent Annual Report on Form 10-K, this Form 10-Q, as well as the other documents filed by us from time to time with the U.S. Securities and Exchange Commission (“SEC”). We operate in a rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Form 10-Q. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
4

The forward-looking statements contained in this Form 10-Q are based on information available to us at the time of filing of this Form 10-Q and relate only to events as of the date on which the statements are made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

5

Part I. - Financial Information
Item 1. Financial Statements.
Planet Labs PBC
Condensed Consolidated Balance Sheets (Unaudited)
 
(in thousands, except share and par value amounts)
July 31, 2024January 31, 2024
Assets 
Current assets 
Cash and cash equivalents$148,288 $83,866 
Restricted cash and cash equivalents, current8,8028,360
Short-term investments101,102215,041
Accounts receivable, net of allowance of $668 and $1,539, respectively
43,92643,320
Prepaid expenses and other current assets24,62819,564
Total current assets326,746370,151
Property and equipment, net113,227113,429
Capitalized internal-use software, net17,32214,973
Goodwill137,325136,256
Intangible assets, net30,40532,448
Restricted cash and cash equivalents, non-current9,5399,972
Operating lease right-of-use assets21,70322,339
Other non-current assets2,0842,429
Total assets$658,351 $701,997 
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable$2,392 $2,601 
Accrued and other current liabilities56,83944,779
Deferred revenue64,52372,327
Liability from early exercise of stock options7,1718,964
Operating lease liabilities, current8,7557,978
Total current liabilities139,680136,649
Deferred revenue11,9695,293
Deferred hosting costs7,9637,101
Public and private placement warrant liabilities2,0332,961
Operating lease liabilities, non-current15,21816,952
Contingent consideration2,4915,885
Other non-current liabilities5,7509,138
Total liabilities185,104183,979
Commitments and contingencies (Note 9)
Stockholders’ equity
Common stock, $0.0001 par value, 570,000,000, 30,000,000 and 30,000,000 Class A, Class B and Class C shares authorized at July 31, 2024 and January 31, 2024, 272,318,817 and 268,117,905 Class A shares issued and outstanding at July 31, 2024 and January 31, 2024, respectively, 21,157,586 Class B shares issued and outstanding at July 31, 2024 and January 31, 2024, 0 Class C shares issued and outstanding at July 31, 2024 and January 31, 2024
2828
Additional paid-in capital1,619,7381,596,201
Accumulated other comprehensive income1,2471,594
Accumulated deficit(1,147,766)(1,079,805)
Total stockholders’ equity473,247518,018
Total liabilities and stockholders’ equity$658,351 $701,997 
See accompanying notes to unaudited condensed consolidated financial statements.
6


Planet Labs PBC
Condensed Consolidated Statements of Operations (Unaudited)

 Three Months Ended July 31,Six Months Ended July 31,
(in thousands, except share and per share amounts)
2024202320242023
Revenue$61,092 $53,761 $121,532 $106,464 
Cost of revenue28,782 27,469 57,539 52,025 
Gross profit32,310 26,292 63,993 54,439 
Operating expenses
Research and development27,250 26,741 52,839 54,927 
Sales and marketing23,733 22,310 45,218 45,435 
General and administrative20,904 20,521 40,084 42,049 
Total operating expenses71,887 69,572 138,141142,411 
Loss from operations(39,577)(43,280)(74,148)(87,972)
Interest income2,771 3,802 5,878 8,308 
Change in fair value of warrant liabilities(602)1,226 928 7,171 
Other income (expense), net(363)859 720 963 
Total other income, net1,806 5,887 7,526 16,442 
Loss before provision for income taxes(37,771)(37,393)(66,622)(71,530)
Provision for income taxes897 582 1,339 889 
Net loss$(38,668)$(37,975)$(67,961)$(72,419)
Basic and diluted net loss per share attributable to common stockholders$(0.13)$(0.14)$(0.23)$(0.26)
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders290,364,319275,053,198289,328,033273,723,006
                        

See accompanying notes to unaudited condensed consolidated financial statements.
7


Planet Labs PBC
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

 Three Months Ended July 31,Six Months Ended July 31,
(in thousands)2024202320242023
Net loss$(38,668)$(37,975)$(67,961)$(72,419)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment323 169 (211)124 
Change in fair value of available-for-sale securities376 (515)(136)(1,059)
Other comprehensive income (loss), net of tax699 (346)(347)(935)
Comprehensive loss$(37,969)$(38,321)$(68,308)$(73,354)

See accompanying notes to unaudited condensed consolidated financial statements.
8

Planet Labs PBC
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)
(in thousands, except share amounts)
 Common Stock Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Total
Stockholders’
Equity
 Shares Amount
Balances at January 31, 2023271,783,561$27 $1,513,102 $2,271 $(939,296)$576,104 
Issuance of Class A common stock from the exercise of common stock options1,018,3853,2953,295
Issuance of Class A common stock upon vesting of restricted stock units1,278,161
Vesting of early exercised stock options91,911896896
Class A common stock withheld to satisfy employee tax withholding obligations(472,136)(1,896)(1,896)
Stock-based compensation15,98315,983
Net unrealized loss on available-for-sale securities, net of taxes(544)(544)
Change in translation(45)(45)
Net loss(34,444)(34,444)
Balances at April 30, 2023273,699,882$27 $1,531,380 $1,682 $(973,740)$559,349 
Issuance of Class A common stock from the exercise of common stock options1,383,4133,0633,063
Issuance of Class A common stock upon vesting of restricted stock units2,597,964
Vesting of early exercised stock options91,910896896
Class A common stock withheld to satisfy employee tax withholding obligations(827,964)(2,857)(2,857)
Stock-based compensation17,43817,438
Net unrealized loss on available-for-sale securities, net of taxes(515)(515)
Change in translation169169
Net loss(37,975)(37,975)
Balances at July 31, 2023276,945,205271,549,9201,336(1,011,715)539,568
 Common Stock Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Accumulated
Deficit
 
Total
Stockholders’
Equity
 Shares Amount
Balances at January 31, 2024289,275,491$28 $1,596,201 $1,594 $(1,079,805)$518,018 
Issuance of Class A common stock from the exercise of common stock options35,3182020
Issuance of Class A common stock upon vesting of restricted stock units2,334,916
Vesting of early exercised stock options896896
Class A common stock withheld to satisfy employee tax withholding obligations(908,417)(2,015)(2,015)
Stock-based compensation13,74513,745
Net unrealized loss on available-for-sale securities, net of taxes(512)(512)
Change in translation(534)(534)
Net loss— (29,293)(29,293)
Balances at April 30, 2024290,737,308$28 $1,608,847 $548 $(1,109,098)$500,325 
Issuance of Class A common stock from the exercise of common stock options234,443280280
Issuance of Class A common stock upon vesting of restricted stock units3,834,734
Vesting of early exercised stock options896896
Class A common stock withheld to satisfy employee tax withholding obligations(1,330,082)(2,470)(2,470)
Stock-based compensation12,18512,185
Net unrealized gain on available-for-sale securities, net of taxes376376
Change in translation323323
Net loss— (38,668)(38,668)
Balances at July 31, 2024293,476,403$28 $1,619,738 $1,247 $(1,147,766)$473,247 

See accompanying notes to unaudited condensed consolidated financial statements.
9

Planet Labs PBC
Condensed Consolidated Statements of Cash Flows (Unaudited)

 Six Months Ended July 31,
(in thousands)2024 2023
Operating activities 
Net loss$(67,961)$(72,419)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization26,248 22,408 
Stock-based compensation, net of capitalized cost of $1,292 and $1,408, respectively
24,638 32,013 
Change in fair value of warrant liabilities(928)(7,171)
Change in fair value of contingent consideration1,924 (527)
Other(1,275)(2,747)
Changes in operating assets and liabilities
Accounts receivable32 (1,588)
Prepaid expenses and other assets1,278 5,152 
Accounts payable, accrued and other liabilities4,084 (17,164)
Deferred revenue(1,149)19,957 
Deferred hosting costs954 1,082 
Net cash used in operating activities(12,155)(21,004)
Investing activities
Purchases of property and equipment(25,061)(21,709)
Capitalized internal-use software(2,916)(1,998)
Maturities of available-for-sale securities46,808 106,762 
Sales of available-for-sale securities150,211 990 
Purchases of available-for-sale securities(81,656)(127,703)
Business acquisition, net of cash acquired(1,068) 
Purchases of licensed imagery intangible assets(4,292) 
Other(300)(644)
Net cash provided by (used in) investing activities81,726 (44,302)
Financing activities
Proceeds from the exercise of common stock options300 6,358 
Shares repurchased for tax withholdings on vesting of restricted stock units
(4,485)(4,753)
Proceeds from employee stock purchase plan702  
Payments of contingent consideration for business acquisitions(1,283) 
Other(340)(15)
Net cash provided by (used in) financing activities(5,106)1,590 
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents(34)155 
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents64,431 (63,561)
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period102,198 188,076 
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period$166,629 $124,515 


See accompanying notes to unaudited condensed consolidated financial statements.


10

Planet Labs PBC
Notes to Unaudited Condensed Consolidated Financial Statements

(1)Organization

Planet Labs PBC (“Planet,” or the “Company”) was founded to design, construct, and launch constellations of satellites with the intent of providing high cadence geospatial data delivered to customers via an online platform. The Company’s mission is to use space to help life on Earth, by imaging the world every day and making global change visible, accessible, and actionable. The Company is headquartered in San Francisco, California, with operations throughout the United States (U.S.”), Canada, Asia and Europe.
On July 7, 2021, Planet Labs Inc. (“Former Planet”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with dMY Technology Group, Inc. IV (“dMY IV”), a special purpose acquisition company (“SPAC”) incorporated in Delaware on December 15, 2020, Photon Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of dMY IV (“First Merger Sub”), and Photon Merger Sub Two, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of dMY IV (“Second Merger Sub”). Pursuant to the Merger Agreement, upon the favorable vote of dMY IV’s stockholders on December 3, 2021, on December 7, 2021, First Merger Sub merged with and into Former Planet (the “Surviving Corporation”), with Former Planet surviving the merger as a wholly owned subsidiary of dMY IV (the “First Merger”), and pursuant to Former Planet’s election immediately following the First Merger and as part of the same overall transaction as the First Merger, the Surviving Corporation merged with and into dMY IV, with dMY IV surviving the merger (the “Business Combination”). Following the completion of the Business Combination, dMY IV was renamed Planet Labs PBC.
Former Planet was incorporated in the state of Delaware on December 28, 2010. Former Planet was originally incorporated as Cosmogia Inc., and the name was subsequently changed to Planet Labs Inc. on June 24, 2013.

(2)Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
The accompanying condensed consolidated financial statements are unaudited; however, in the opinion of management they include all normal and recurring adjustments necessary for a fair presentation of the Company’s unaudited condensed consolidated financial statements for the periods presented. Operating results for the three and six months ended July 31, 2024 are not necessarily indicative of the results expected for the fiscal year ending January 31, 2025 or any other future period.
The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) and include the accounts of Planet Labs PBC and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company’s fiscal year end is January 31.
Certain notes or other information that are normally required by U.S. GAAP have been condensed or omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024 (the “2024 Form 10-K”).
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant estimates and assumptions that affect the Company’s unaudited condensed consolidated financial statements include, but are not limited to, the useful lives of property and equipment, capitalized internal-use software and intangible assets, the Company’s incremental borrowing rate for operating leases, allowances for credit losses for available-for-sale debt securities and accounts receivable, estimates related to revenue recognition, including the assessment of performance obligations within a contract and the determination of standalone selling price (“SSP”) for each performance obligation, assumptions used to measure stock-based compensation, the fair value of private placement warrant liabilities, the fair value of assets acquired and liabilities assumed from business combinations, the fair value of contingent consideration for business combinations, the impairment of long-lived assets and goodwill, the recognition, measurement and valuation of current and deferred income taxes and uncertain tax positions, and contingencies.
These estimates and assumptions are based on management’s best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, due to the inherent
11

uncertainties in making estimates, actual results could differ from those estimates and such differences may be material.
Due to current geopolitical events, including the war in Ukraine and the Israel-Hamas conflict, there is ongoing uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities. These estimates and assumptions may change in the future, as new events occur, and additional information is obtained.
Segments
Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating segment and one reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.
See Note 3, Revenue, for revenue by geographic region. See Note 5, Balance Sheet Components, for long-lived assets by geographic region.
Concentration of Credit Risk and Other Risks and Uncertainties
Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. By their nature, all such financial instruments involve risks, including the credit risk of nonperformance by counterparties. The Company’s cash, cash equivalents and short-term investments are deposited with or held by financial institutions in the U.S., Canada, Germany, the Netherlands, Slovenia, Austria, and Singapore. The Company generally does not require collateral to support the obligations of the counterparties and deposits at financial institutions may, at times, be in excess of federal or national insured limits or deposit-guarantee limits in each of the respective countries. The Company has not experienced material losses on its deposits. The maximum amount of loss at July 31, 2024 that the Company would incur if parties to cash, cash equivalents, and short-term investments failed completely to perform according to the terms of the contracts is $247.2 million.
Accounts receivable are typically unsecured and are derived from revenue earned from customers across various countries. One customer accounted for 14% of accounts receivable as of July 31, 2024. As of January 31, 2024, no customer accounted for 10% or more of accounts receivable.
For the three and six months ended July 31, 2024, one customer accounted for 21% and 20% of revenue, respectively. For the three and six months ended July 31, 2023, one customer accounted for 23% and 22% of revenue, respectively.
The Company’s offerings depend on continued and new approvals from the Federal Communications Commission (“FCC”), National Oceanic and Atmospheric Administration (“NOAA”), and other U.S. and international regulatory agencies for the Company to continue its operations. There can be no assurance that the Company’s operations will continue to receive the necessary approvals or that such operations will be supported by the U.S. government or other governments. If the Company was denied such approvals, if such approvals were delayed, or if the U.S. government’s or other governments’ policies change, these events may have a material adverse impact on the Company’s financial position and results of operations.
Significant Accounting Policies
The Company’s significant accounting policies are included in Note 2 of its Consolidated Financial Statements included in the 2024 Form 10-K.
Recent Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures, which clarifies that entities with a single reportable segment are subject to both new and existing segment reporting requirements under ASC 280, and modifies certain segment disclosure requirements. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (“Topic 740”): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures, primarily through changes around the effective tax rate reconciliation and income taxes paid information. The guidance is effective for
12

annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statements and related disclosures.

(3)Revenue
Deferred Revenue
During the six months ended July 31, 2024 and 2023, the Company recognized revenue of $46.7 million and $38.5 million, respectively, that had been included in deferred revenue as of January 31, 2024 and 2023, respectively.

Remaining Performance Obligations
The Company often enters into multi-year imagery licensing arrangements with its customers, whereby the Company generally invoices the amount for the first year of the contract at signing followed by subsequent annual invoices. Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized, which includes both deferred revenue and non-cancelable contracted revenue that will be invoiced and recognized in revenue in future periods. The Company’s remaining performance obligations were $112.1 million as of July 31, 2024, which consists of both deferred revenue of $76.5 million and non-cancelable contracted revenue that will be invoiced in future periods of $35.6 million. The Company expects to recognize approximately 78% of the remaining performance obligation over the next 12 months, approximately 97% of the remaining obligation over the next 24 months, and the remainder thereafter.
Remaining performance obligations do not include unexercised contract options, written orders where funding has not been appropriated and contracts which provide the customer with a right to terminate for convenience without incurring a substantive termination penalty.

Disaggregation of Revenue
The following table disaggregates revenue by major geographic region:
 Three Months Ended July 31,Six Months Ended July 31,
(in thousands)2024202320242023
United States$28,755 $27,038 $57,815 $50,165 
Rest of world32,33726,72363,71756,299
Total revenue$61,092 $53,761 $121,532 $106,464 
No single country other than the U.S. accounted for more than 10% of revenue for the three and six months ended July 31, 2024 and 2023.

Costs to Obtain and Fulfill a Contract
Commissions paid to the Company’s direct sales force are considered incremental costs of obtaining a contract with a customer. Accordingly, commissions are capitalized when incurred and amortized to sales and marketing expense over the period of benefit from the underlying contracts. The period of benefit from the underlying contract is consistent with the timing of transfer to the performance obligations to which the capitalized costs relate, and is generally consistent with the contract term.
During the three and six months ended July 31, 2024, the Company capitalized $0.5 million and $0.7 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.6 million and $1.3 million for the three and six month periods ended July 31, 2024, respectively.
During the three and six months ended July 31, 2023, the Company capitalized $0.4 million and $0.6 million of deferred commission expenditures to be amortized in future periods, respectively. The Company’s amortization of deferred commission expenditures was $0.7 million and $1.3 million for the three and six month periods ended July 31, 2023, respectively.
13

As of July 31, 2024 and January 31, 2024, deferred commissions consisted of the following:
(in thousands)July 31, 2024January 31, 2024
Deferred commission, current$2,015 $2,296 
Deferred commission, non-current1,1971,578
Total deferred commission$3,212 $3,874 
The current portion of deferred commissions are included in prepaid expenses and other current assets on the condensed consolidated balance sheets. The non-current portion of deferred commissions are included in other non-current assets on the condensed consolidated balance sheets.

(4)Fair Value of Financial Assets and Liabilities
Assets and liabilities recognized or disclosed at fair value in the financial statements are categorized based upon the level of judgment associated with the inputs used to measure their respective fair values.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis for recognition or disclosure purposes as of July 31, 2024 and January 31, 2024 by level within the fair value hierarchy. Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and considers factors specific to the asset or liability.
 July 31, 2024
(in thousands)Level 1 Level 2 Level 3
Assets
Cash equivalents:
Money market funds$36,081 $ $ 
Restricted cash equivalents: money market funds16,868   
Short-term investments:
U.S. Treasury securities6,454 $ $ 
Commercial paper 3,049 $ 
Corporate bonds 88,422 $ 
Certificates of deposit 3,177 $ 
Total assets$59,403 $94,648 $ 
Liabilities
Public Warrants$1,173 $ $ 
Private Placement Warrants $ 860 
Contingent consideration for acquisitions $ 13,545 
Total liabilities$1,173 $ $14,405 
14

 January 31, 2024
(in thousands)Level 1Level 2Level 3
Assets
Cash equivalents:
Money market funds$28,722 $ $ 
Restricted cash equivalents: money market funds17,301
Short-term investments:
U.S. Treasury securities46,211
Commercial paper11,126
Corporate bonds144,340
U.S. government agency securities9,933
Certificates of deposit3,431
Total assets$92,234 $168,830 $ 
Liabilities
Public Warrants$1,656 $ $ 
Private Placement Warrants1,305
Contingent consideration for acquisitions  12,891 
Total liabilities$1,656 $ $14,196 
The fair value of cash held in banks and accrued and other current liabilities approximate the stated carrying value due to the short time to maturity and are excluded from the tables above.
Money Market Funds
The fair value of the Company’s money market funds is based on quoted active market prices for the funds and is determined using the market approach. There were no realized or unrealized gains or losses on money market funds for the three and six months ended July 31, 2024 and 2023.
Short-term Investments
The fair value of the Company’s short-term investments classified within Level 1 are valued using quoted active market prices for the securities. The fair value of the Company’s short-term investments classified within Level 2 are valued using third-party pricing services. The pricing services utilize industry standard valuation models. Inputs utilized include market pricing based on real-time trade data for the same or similar securities and other significant inputs derived from or corroborated by observable market data.
Public and Private Placement Warrants
The Public Warrants are classified within Level 1 as they are publicly traded and had an observable market price in an active market.
The Private Placement Warrants (excluding the Private Placement Vesting Warrants) were valued based on a Black-Scholes option pricing model. Due to the market condition vesting requirements, the fair value of the Private Placement Vesting Warrants were valued using a model based on multiple stock price paths developed through the use of a Monte Carlo simulation that incorporates into the valuation the possibility that the market condition targets may not be satisfied. The Private Placement Warrants were collectively classified as a Level 3 measurement within the fair value hierarchy because these valuation models involve the use of unobservable inputs relating to the Company’s estimate of its expected stock volatility. The expected volatility input utilized for the fair value measurements of the Private Placement Warrants as of July 31, 2024 and January 31, 2024 was 65% and 70%, respectively.
Contingent Consideration for Acquisitions
The Company has recorded contingent consideration liabilities in connection with its acquisitions of Salo Sciences and Sinergise (see Note 6 of the Company’s Consolidated Financial Statements included in the 2024 Form 10-K). The Company measures the fair value of the contingent consideration liabilities based on significant inputs not observable in the market, which caused them to be classified as a Level 3 measurement within the fair value hierarchy.
The fair value of the contingent consideration liability for the Salo Sciences technical milestone payments is determined based on the present value of the probability-weighted payments for each of the two milestones. The
15

significant unobservable inputs used in the fair value measurement are management’s estimate of the probability to achieve the technical milestone criteria and the discount rate. The Company determined that both of the technical milestone criteria were achieved during the three months ended July 31, 2024.
The fair value of the contingent consideration liability for the Salo Sciences customer contract earnout payments is determined using a Monte Carlo simulation. The fair value estimate involves a simulation of future customer contract cash collections during the four-year performance period, the probability of entering into contracts with the named customers and discounting the probability-weighed earnout payments to present value. The significant unobservable inputs used in the fair value measurement are management’s estimate of obtaining the customer contracts, including probabilities, timing and contract values, and management’s estimate of the discount rate.
The fair value of the contingent consideration liability for the Sinergise customer consent escrow is determined based on the present value of the probability-weighted payments based on the likelihood of the customer consent being achieved. The significant unobservable input used in the fair value measurement is management’s estimate of the likelihood of the customer consent being achieved.
Level 3 Disclosures
The following is a roll-forward of Level 3 liabilities measured at fair value for the three and six months ended July 31, 2024 and 2023:
(in thousands)Private Placement WarrantsTechnical Milestone Contingent Consideration*Customer Contract Earnout Contingent Consideration*Customer Consent Escrow Contingent Consideration*
Fair value at end of year, January 31, 2023$9,701 $4,433 $3,597 $ 
Change in fair value(3,323)5(428)
Fair value at April 30, 2023$6,378 $4,438 $3,169 $ 
Change in fair value(1,364)211(315)
Fair value at July 31, 2023$5,014 $4,649 $2,854 $ 
Fair value at end of year, January 31, 2024$1,305 $5,114 $1,926 $5,851 
Payments(180)
Change in fair value(771)(183)1369
Fair value at April 30, 2024$534 $4,931 $1,759 $5,920 
Payments(1,090)
Change in fair value3265791551,291
Fair value at July 31, 2024$860 $5,510 $824 $7,211 
* The current portion of the contingent consideration liabilities balances of $11.1 million and $7.0 million as of July 31, 2024 and January 31, 2024, respectively, are included within accrued and other current liabilities. Changes in fair value of the contingent consideration liability for the Salo Sciences technical milestone payments are included within research and development expenses. Changes in fair value of the Salo Sciences contingent consideration liability for customer contract earnout payments are included within sales and marketing expenses. Changes in fair value of the contingent consideration liability for the Sinergise acquisition escrow payments are included within general and administrative expenses.
Other
The Company measures certain non-financial assets including property and equipment, and other intangible assets at fair value on a non-recurring basis in periods after initial measurement in circumstances when the fair value of such assets are impaired below their recorded cost. As of July 31, 2024 and January 31, 2024, there were no material non-financial assets recorded at fair value.

16

(5)Balance Sheet Components
Cash and Cash Equivalents, and Restricted Cash and Cash Equivalents
Cash and cash equivalents include interest-bearing bank deposits, money market funds and other highly liquid investments with maturities of 90 days or less at the date of purchase.
The Company had restricted cash and cash equivalents balances of $18.3 million and $18.3 million as of July 31, 2024 and January 31, 2024, respectively.
The restricted cash and cash equivalents balances as of July 31, 2024 and January 31, 2024 primarily consisted of $12.5 million of consideration placed in escrow in connection with the Sinergise acquisition and $4.0 million of collateral money market investments for the Company’s headquarters and other domestic office operating leases.
A reconciliation of the Company’s cash and cash equivalents and restricted cash and cash equivalents in the condensed consolidated balance sheets to total cash and cash equivalents, and restricted cash and cash equivalents in the condensed consolidated statements of cash flows as of July 31, 2024 and January 31, 2024 is as follows:
 
(in thousands)July 31, 2024January 31, 2024
Cash and cash equivalents$148,288 $83,866 
Restricted cash and cash equivalents, current8,802 8,360
Restricted cash and cash equivalents, non-current9,539 9,972
Total cash, cash equivalents, and restricted cash and cash equivalents$166,629 $102,198 
Short-term Investments
Short-term investments consisted of the following as of July 31, 2024 and January 31, 2024:
July 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$6,487 $ $(33)$6,454 
Commercial paper3,049   3,049 
Corporate bonds88,274 160 (12)88,422 
Certificates of deposit3,177   3,177 
Total short-term investments$100,987 $160 $(45)$101,102 
January 31, 2024
Gross Unrealized
(in thousands)Cost or Amortized CostGainsLossesFair Value
U.S Treasury securities$46,185 $118 $(92)$46,211 
Commercial paper11,126   11,126 
Corporate bonds144,119 376 (155)144,340 
U.S. government agency securities9,928 17 (13)9,932 
Certificates of deposit3,432   3,432 
Total short-term investments$214,790 $511 $(260)$215,041 
17

The following table summarizes the contracted maturities of the Company’s short-term investments as of July 31, 2024 and January 31, 2024:
July 31, 2024January 31, 2024
(in thousands)Amortized CostFair ValueAmortized CostFair Value
Due in 1 year or less$66,753 $66,803 $148,396 $148,296 
Due in 1-2 years34,234 34,299 66,394 66,745 
$100,987 $101,102 $214,790 $215,041 
Property and Equipment, Net
Property and equipment, net consists of the following:
(in thousands)July 31, 2024January 31, 2024
Satellites$271,868 $300,203 
Satellites in process and not placed into service51,504 32,468 
Leasehold improvements17,124 17,089 
Ground stations and ground station equipment19,951 19,098 
Office furniture, equipment and fixtures9,337 8,044 
Computer equipment and purchased software9,615 9,446 
Total property and equipment, gross$379,399 $386,348 
Less: Accumulated depreciation(266,172)(272,919)
Total property and equipment, net$113,227 $113,429 

The Company’s long-lived assets by geographic region are as follows:
(in thousands)July 31, 2024January 31, 2024
United States$107,006 $107,070 
Rest of world
6,2216,359
Total property and equipment, net$113,227 $113,429 
The Company concluded that satellites in service continue to be owned by the U.S. entity and accordingly are classified as U.S. assets in the table above. No single country other than the U.S. accounted for more than 10% of total property and equipment, net, as of July 31, 2024 and January 31, 2024.
Total depreciation expense for the three and six months ended July 31, 2024 was $11.2 million and $22.2 million, respectively, of which $10.4 million and $20.7 million, respectively, was depreciation expense specific to satellites. Total depreciation expense for the three and six months ended July 31, 2023 was $10.8 million and $19.5 million, respectively, of which $10.2 million and $18.4 million, respectively, was depreciation expense specific to satellites.
Capitalized Internal-Use Software Development Costs
Capitalized internal-use software costs, net of accumulated amortization consists of the following:
(in thousands)July 31, 2024January 31, 2024
Capitalized internal-use software$48,537 $45,010 
Less: Accumulated amortization(31,215)(30,037)
Capitalized internal-use software, net$17,322 $14,973 
Amortization expense for capitalized internal-use software for the three and six months ended July 31, 2024 was $0.6 million and $1.2 million, respectively. Amortization expense for capitalized internal-use software for the three and six months ended July 31, 2023 was $0.5 million and $0.9 million, respectively.
18

Goodwill and Intangible Assets
Goodwill and Intangible assets consists of the following:
 July 31, 2024
January 31, 2024
(in thousands)Gross
Carrying
Amount
Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
 Gross
Carrying
Amount
 Accumulated
Amortization
 Foreign
Currency
Translation
 Net
Carrying
Amount
Developed technology$30,429 $(12,453)$(237)$17,739 $30,429 $(11,085)$(220)$19,124 
Image library19,710(12,624)3237,40919,324(11,852)2187,690
Customer relationships7,143(4,058)(44)3,0417,143(3,715)-423,386
Trade names and other6,389(4,203)302,2166,089(3,877)362,248
Total intangible assets$63,671 $(33,338)$72 $30,405 $62,985 $(30,529)$(8)$32,448 
Goodwill$135,981 $— $1,344 $137,325 $134,914 $— $1,342 $136,256 
Amortization expense for intangible assets for the three and six months ended July 31, 2024 was $1.4 million and $2.8 million, respectively. Amortization expense for intangible assets for the three and six months ended July 31, 2023 was $0.9 million and $2.0 million, respectively.
The change in the carrying amount of goodwill during the six months ended July 31, 2024 and 2023 is as follows:
Six Months Ended
July 31,
(in thousands)20242023
Beginning of period$136,256 $112,748 
Addition1,068  
Currency translation adjustment1  
End of period$137,325 $112,748 
During the six months ended July 31, 2024, the Company paid $1.1 million of additional consideration in connection with the finalization of the net working capital adjustment relating to the Company’s acquisition of Sinergise. The acquisition of Sinergise was completed on August 4, 2023. The additional amount was accounted for as a measurement period adjustment and resulted in a $1.1 million addition of goodwill during the six months ended July 31, 2024.
Accrued and Other Current Liabilities
Accrued liabilities and other current liabilities consist of the following:
(in thousands)July 31, 2024January 31, 2024
Deferred R&D service liability (see Note 8)$10,596 $9,923 
Payroll and related expenses7,088 6,859 
Deferred hosting costs5,099 5,007 
Withholding taxes and other taxes payable2,222 3,152 
Contingent consideration
11,0547,006
Severance and other employee termination costs8,01523
Other accruals
12,76512,809
Total accrued and other current liabilities$56,839 $44,779 

(6)Restructuring
In June 2024, the Company announced a plan to reduce its global headcount by approximately 17% of the Company’s total number of employees prior to the reduction (the “headcount reduction”). This action was taken consistent with the Company’s ongoing focus on aligning its resources to the market opportunity, improving operational efficiency, and supporting the long-term growth of the business.
19

As a result of the headcount reduction, the Company recognized $10.5 million of costs during the three and six months ended July 31, 2024 for one-time employee termination benefits consisting of severance and other employee costs. A summary of the restructuring charge recognized during the three and six months ended July 31, 2024 is provided in the table below:
(in thousands)Severance and Other Employee Costs
Cost of revenue$1,184 
Research and development3,540 
Sales and marketing4,433 
General and administrative1,342 
Total restructuring charges$10,499 
There were no restructuring charges recognized during the three and six months ended July 31, 2023.
The following table summarizes the Company’s liability recognized in connection with the headcount reduction, which is recorded within accrued and other current liabilities in the condensed consolidated balance sheets:
(in thousands)
Balance as of January 31, 2024$ 
Severance and other employee costs10,499 
Cash payments(2,484)
Balance as of July 31, 2024$8,015 
The headcount reductions, including the remaining cash payments, are expected to be substantially complete by the end of the fiscal year ending January 31, 2025.

(7)Leases
The Company’s leasing activities primarily consist of real estate leases for its operations, including office space, and certain ground station service agreements that convey the right to control the use of specified equipment and facilities. The Company assesses whether each lease is an operating or finance lease at the lease commencement date. As of July 31, 2024, the Company had no finance leases.
Operating lease costs were $2.4 million and $4.7 million for the three and six months ended July 31, 2024, respectively. Operating lease costs were $2.1 million and $4.0 million for the three and six months ended July 31, 2023, respectively. Variable lease expenses and short-term lease expenses were immaterial for the three and six months ended July 31, 2024 and 2023.
Operating cash flows from operating leases were $2.6 million and $5.0 million for the three and six months ended July 31, 2024, respectively. Operating cash flows from operating leases were $1.7 million and $2.7 million for the three and six months ended July 31, 2023, respectively.
Right of use assets obtained in exchange for operating lease liabilities were $2.7 million and $3.1 million for the three and six months ended July 31, 2024, respectively. Right of use assets obtained in exchange for operating lease liabilities were $1.3 million and $6.2 million for the three and six months ended July 31, 2023, respectively.
20

Maturities of operating lease liabilities as of July 31, 2024 were as follows:
(in thousands)
Remainder of Fiscal Year 2025$5,156
20269,950
20276,837
20282,684
20291,587
Thereafter605
Total lease payments$26,819
Less: Imputed interest(2,846)
Total lease liabilities$23,973
Weighted average remaining lease term (years)3.0
Weighted average discount rate8 %

(8)Research and Development Arrangements
Research and Development Services Agreement
In December 2020, the Company entered into a development services agreement, whereby the Company agreed to provide the technical knowledge and services to design and develop certain prototype satellites and deliver and test early data collected (the “R&D Services Agreement”). The R&D Services Agreement, including subsequent amendments to such agreement, provides for funding of $46.4 million to be paid to the Company as specified milestones are achieved. The R&D Services Agreement is unrelated to the Company’s ordinary business activities. The Company has discretion in managing the activities under the R&D Services Agreement and retains all developed intellectual property. The Company has no obligation to repay any of the funds received regardless of the outcome of the development work; therefore, the arrangement is accounted for as funded research and development pursuant to ASC 730-20, Research and Development. As ASC 730-20 does not indicate the accounting model for research and development services, the Company determined the total transaction price is recognized over the agreement term as a reduction of research and development expenses based on a cost incurred method.
During the three and six months ended July 31, 2024, the Company recognized $1.1 million and $4.3 million of funding and incurred $1.2 million and $3.6 million of research and development expenses, respectively, in connection with the R&D Services Agreement. During the three and six months ended July 31, 2023, the Company recognized $3.9 million and $8.0 million of funding and incurred $3.9 million and $8.0 million of research and development expenses, respectively. As of July 31, 2024 and January 31, 2024, the Company had received a total of $46.4 million and $45.8 million, respectively, of funding under the R&D Services Agreement.
NASA Communication Services Project
In connection with its Communication Services Project (“CSP”), the National Aeronautics and Space Administration (“NASA”) selected certain satellite communications providers that NASA will fund to develop and demonstrate near-Earth space communication services that may support future NASA missions using commercial technology. In June 2022 and August 2022, the Company entered into separate agreements with two of the satellite communications providers selected by NASA whereby the Company agreed to participate in the NASA CSP as a subcontractor. The agreements provide for the Company to receive aggregate funding of $40.5 million to be paid as milestones are completed. The Company determined that the agreements are in the scope of ASC 912-730, Contractors – Federal Government – Research and Development (“ASC 912-730”). In accordance with ASC 912-730, funding is recognized over the term of each agreement as a reduction of research and development expenses based on a cost incurred method.
During the three and six months ended July 31, 2024, the Company recognized $2.5 million and $5.1 million of funding, respectively, and incurred $2.5 million and $5.1 million of research and development expenses, respectively, in connection with the NASA CSP. During the three and six months ended July 31, 2023, the Company recognized $4.9 million and $8.0 million of funding, respectively, and incurred $3.3 million and $7.2 million of research and development expenses, respectively, in connection with the NASA CSP. As of July 31, 2024 and January 31, 2024, the Company had received a total of $22.6 million and $13.9 million, respectively, of funding in connection with the NASA CSP.
21

In July 2023, projected costs related to certain of our research and development arrangements were revised down as a result of operational decisions. This change in estimate resulted in a $2.2 million cumulative increase of funding recognized for certain of our research and development arrangements for the three months ended July 31, 2023.

(9)Commitments and Contingencies
Other
The Company has minimum purchase commitments for hosting services from Google through January 31, 2028 (see Note 11). Future minimum purchase commitments under the noncancelable hosting service agreement with Google as of July 31, 2024 are as follows:
(in thousands) 
Remainder of Fiscal Year 2025$16,837 
202631,190 
202732,725 
202833,427 
Total purchase commitments$114,179 

Legal Proceedings
Delaware Class Action
A stockholder class action was filed in the Court of Chancery of the State of Delaware on August 19, 2024, against the former officers and directors of dMY IV and the Company. The complaint alleges that the individual defendants breached various fiduciary duties to the dMY IV stockholders and that the Company aided and abetted such breaches. The case is brought on behalf of a purported class of holders of dMY IV Class A Common Stock who held such stock prior to the redemption deadline for the Business Combination, did not exercise the right to redeem their shares, and were allegedly injured. The case is in its earliest stages and defendants have not yet responded to the complaint.
For many legal matters, particularly those in early stages, the Company cannot reasonably estimate the possible loss (or range of loss), if any. The Company records an accrual for legal matters at the time or times it determines that a loss is both probable and reasonably estimable. Regarding matters for which no accrual has been made (including the potential for losses in excess of amounts accrued), the Company currently believes, based on its own investigations, that any losses (or ranges of losses) that are reasonably possible and estimable will not, in the aggregate, have a material adverse effect on its financial position, results of operations, or cash flows. However, the ultimate outcome of legal proceedings involves judgments, estimates, and inherent uncertainties and cannot be predicted with certainty. Should the ultimate outcome of any legal matter be unfavorable, the Company's business, financial condition, results of operations, or cash flows could be materially and adversely affected. The Company may also incur substantial legal fees, which are expensed as incurred, in defending against legal claims.
Contingencies
The Company may have certain contingent liabilities that arise in the ordinary course of business activities including those arising from disputes and claims and events arising from revenue contracts entered into by the Company. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.
Indemnification
The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent, or other intellectual property infringement claim by any third-party with respect to its technology. The term of these indemnification agreements is generally perpetual after the execution of the agreement. The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. In the event that one or more of these matters were to result in a claim against the Company, an adverse outcome, including a judgment or settlement, may cause a material adverse effect on the Company’s future business, operating results or financial condition. It is not possible to determine the maximum potential amount under these contracts due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement.
22

The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify them against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.
To date, we have not incurred any material costs, and have not accrued any liabilities in the consolidated financial statements as a result of these provisions.

(10)Warrants
Public and Private Placement Warrants
In connection with dMY IV’s initial public offering, which occurred on March 9, 2021, dMY IV issued 34,500,000 units, each unit consisting of one share of Class A common stock of dMY IV and one-fifth of one redeemable warrant, at a price of $10.00 per unit. Each whole warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (the “Public Warrants”). Simultaneously with the closing of its initial public offering, dMY IV completed the private sale of 5,933,333 warrants to dMY Sponsor IV, LLC (the “dMY Sponsor”) at a purchase price of $1.50 per warrant (the “Private Placement Warrants”). Each Private Placement Warrant is exercisable for one share of Class A common stock at $11.50 per share.
Additionally, pursuant to a lock-up agreement entered into with the dMY Sponsor in connection with the Business Combination, 2,966,667 of the Private Placement Warrants are subject to vesting conditions (the “Private Placement Vesting Warrants”). The Private Placement Vesting Warrants vest in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00. Any right to Private Placement Vesting Warrants that remains unvested on the first business day after five years from the closing of the Business Combination will be forfeited without any further consideration.
As of July 31, 2024 and January 31, 2024, there were 6,899,982 Public Warrants and 5,933,333 Private Placement Warrants, including 2,966,667 Private Placement Vesting Warrants, outstanding.
Warrants to Purchase Class A Common Stock
In addition to the Public and Private Placement Warrants, there were 1,065,594 warrants to purchase shares of Class A common stock with a weighted average exercise price of $9.384 which were outstanding and exercisable as of July 31, 2024 and January 31, 2024. As of July 31, 2024, the outstanding warrants have a weighted average remaining term of 5.7 years.

(11)Related Party Transactions
As of July 31, 2024 and January 31, 2024, Google held 31,942,641 shares of the Company’s Class A common stock, and, as such, owned greater than 10% of outstanding shares of the Company’s Class A common stock.
In April 2017, the Company and Google entered into a five year content license agreement pursuant to which the Company licensed content to Google. In April 2022, the agreement automatically renewed for a period of one year and in April 2023, the agreement expired. For the six months ended July 31, 2023, the Company recognized revenue of $0.3 million related to this content license agreement.
In July 2023, the Company and Google entered into a one year content license agreement pursuant to which the Company agreed to license content to Google and provide certain of its products in exchange for a $1.0 million fee. The agreement also provides for the Company to receive up to $2.0 million in value of Google cloud credits that the Company can apply against the cost of Google cloud services it utilizes to fulfill its obligations under the agreement. The Company determined that the Google cloud credits represent non-cash variable consideration which is included in the transaction price for the agreement, subject to the guidance on estimating variable consideration within ASC 606, Revenue from Contracts with Customers. The agreement does not include extension or renewal terms. In August 2024, the content license agreement was amended to extend the term until November 2024 in exchange for a $0.3 million fee. For the six months ended July 31, 2024, the Company recognized immaterial revenue related to the content license agreement. For the three and six months ended July 31, 2023, the Company recognized $1.0 million related to the content license agreement.
23

The Company purchases hosting and other services from Google, of which $13.1 million and $12.1 million is deferred as of July 31, 2024 and January 31, 2024, respectively. The Company recorded $7.5 million of expense during the three months ended July 31, 2024 relating to hosting and other services provided by Google, of which $6.8 million was classified as cost of revenue and $0.7 million was classified as research and development. The Company recorded $14.5 million of expense during the six months ended July 31, 2024 relating to hosting and other services provided by Google, of which $13.0 million was classified as cost of revenue and $1.5 million was classified as research and development.
The Company recorded $7.7 million of expense during the three months ended July 31, 2023 relating to hosting and other services provided by Google, of which $6.9 million was classified as cost of revenue and $0.8 million was classified as research and development. The Company recorded $14.1 million of expense during the six months ended July 31, 2023 relating to hosting and other services provided by Google, of which $12.7 million was classified as cost of revenue and $1.4 million was classified as research and development.
As of July 31, 2024 and January 31, 2024, the Company’s accrued and other current liabilities balance included $2.8 million and $2.5 million related to hosting and other services provided by Google, respectively.
On June 28, 2021, the Company amended the terms of its hosting agreement with Google. The amendment, among other things, increased the aggregate purchase commitments to $193.0 million. The amended agreement commenced on August 1, 2021 and extends through January 31, 2028. See Note 9 for future Google hosting purchase commitments, including the amended commitments, as of July 31, 2024.

(12)Stock-based Compensation
The Company's equity incentive plans are described in Note 16, Stock-based Compensation, in the Notes to the Consolidated Financial Statements in the 2024 Form 10-K.
Stock-Based Compensation
The following table summarizes stock-based compensation expense recognized related to awards granted to employees and nonemployees, as follows:
 Three Months Ended July 31,Six Months Ended July 31,
(in thousands)2024202320242023
Cost of revenue$1,103 $1,147 $2,084 $2,064 
Research and development3,121 7,626 8,852 14,211 
Sales and marketing2,805 3,121 5,208 6,201 
General and administrative5,156 5,544 9,786 10,945 
Total expense12,185 17,438 25,930 33,421 
Capitalized to internal-use software development costs and property and equipment(619)(781)(1,292)(1,408)
Total stock-based compensation expense$11,566 $16,657 $24,638 $32,013 
Stock Options
A summary of stock option activity is as follows:
 Options Outstanding
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Term (Years)
 
Aggregate
Intrinsic
Value
(in thousands)
Balances at January 31, 2024
26,956,953$5.34 5.7
Exercised(269,761)$1.11 
Granted $ 
Forfeited(580,734)$7.72 
Balances at July 31, 2024
26,106,458$5.33 5.2$1,268 
Vested and exercisable at July 31, 2024
24,094,452$5.02 5.0$1,268 
As of July 31, 2024, total unrecognized compensation cost related to stock options was $8.6 million, which is expected to be recognized over a period of 1.2 years.
24

Restricted Stock Units
A summary of Restricted Stock Unit (“RSU”) activity is as follows:
 
Number of
RSUs
 
Weighted
Average
Grant Date
Fair Value
Balances at January 31, 2024
26,718,766$4.45 
Vested(6,036,206)$4.23 
Granted25,881,112$2.33 
Forfeited(2,911,975)$4.15 
Balances at July 31, 2024
43,651,697$3.24 
During the six months ended July 31, 2024, the Company granted 25,881,112 RSUs, which generally vest over four years, subject to the recipient’s continued service through each applicable vesting date.
Stock-based compensation expense recognized for RSUs during the three and six months ended July 31, 2024 was $9.5 million and $20.3 million, respectively. Stock-based compensation expense recognized for RSUs during the three and six months ended July 31, 2023 was $11.3 million and $20.6 million, respectively. As of July 31, 2024, total unrecognized compensation cost related to RSUs was $126.0 million. These costs are expected to be recognized over a period of approximately 3.0 years.
Performance Vesting Restricted Stock Units
During the six months ended July 31, 2024, the Company granted 348,222 performance vesting restricted stock units (“PSUs”) to certain members of the Company’s senior management. A portion of the PSUs are subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the first half of the fiscal year ended January 31, 2025 and the remaining portion is subject to vesting requirements related to the achievement of certain revenue and adjusted EBITDA targets for the entire fiscal year ended January 31, 2025. Vesting is also subject to continued service through the applicable vesting dates, and the actual number of PSUs that may vest ranges from 0% to 125% of the PSUs granted based on achievement of the targets.
Stock-based compensation expense recognized for PSUs during the three and six months ended July 31, 2024 was $0.3 million and $0.5 million, respectively. Stock-based compensation expense recognized for PSUs during the three and six months ended July 31, 2023 was $0.4 million. As of July 31, 2024, total unrecognized compensation cost related to PSUs was $0.4 million. These costs are expected to be recognized over a period of approximately 0.7 years.
Employee Stock Purchase Program
Beginning in April 2024, the Company's eligible employees were able to begin participating in the Company's Employee Stock Purchase Program (“ESPP”). The ESPP allows eligible participants to contribute up to 10% of their eligible compensation towards the purchase of Class A common stock at a discounted price, subject to certain limitations. The purchase price of the shares on each purchase date is equal to 85% of the lower of the fair market value of Class A common stock on the first and last trading days of each offering period. The offerings under the ESPP are currently designed to be intended to qualify under Section 423 of the Internal Revenue Code. The Company estimates the fair value of each purchase right under the ESPP on the date of grant using the Black-Scholes valuation model and uses the straight-line attribution approach to record the expense over the six-month offering period.
Stock-based compensation expense recognized related to ESPP during the three and six months ended July 31, 2024 was $0.2 million and $0.3 million, respectively. As of July 31, 2024, total unrecognized compensation cost related to ESPP was $0.1 million. These costs are expected to be recognized over a period of approximately 0.2 years.
Early Exercises of Stock Options
The Planet Labs Inc. Amended and Restated 2011 Stock Incentive Plan provided for the early exercise of stock options for certain individuals as determined by the Company’s board of directors. Shares of common stock issued upon early exercises of unvested options are not deemed, for accounting purposes, to be issued until those shares vest according to their respective vesting schedules and accordingly, the consideration received for early exercises is initially recorded as a liability and reclassified to common stock and additional paid-in capital as the underlying awards vest. As of July 31, 2024, the Company had a $7.2 million liability recorded for the early exercise of unvested stock options, and the related number of unvested shares subject to repurchase was 735,280.
25

Earn-out Shares
Pursuant to the Merger Agreement, Former Planet equity award holders have the right to receive Earn-out Shares that are contingently issuable in shares of Class A common stock. The Earn-out Shares may be earned in four equal tranches (i) when the closing price of Class A common stock equals or exceeds $15.00, $17.00, $19.00 and $21.00, over any 20 trading days within any 30 day trading period prior to December 7, 2026 or (ii) when the Company consummates a change of control transaction prior to December 7, 2026 that entitles its stockholders to receive a per share consideration of at least $15.00, $17.00, $19.00 and $21.00.
No Earn-out Shares vested during the three and six months ended July 31, 2024. As of July 31, 2024, there were 3,178,315 Earn-out Shares outstanding relating to Former Planet equity award holders.
During the three and six months ended July 31, 2023, the Company recognized $1.6 million and $3.9 million of stock-based compensation expense related to the Earn-out Shares, respectively. As of July 31, 2024, there was no remaining unrecognized compensation cost related to the Earn-out Shares.
Other Stock-based Compensation
In connection with the acquisition of VanderSat B.V. (“VanderSat”) on December 13, 2021, the Company issued 543,391 shares of Class A common stock to an employee and former owner of VanderSat which are accounted for as stock-based compensation because the shares were subject to forfeiture based on post-acquisition time-based service vesting. The shares vested in quarterly increments over two years commencing on December 13, 2021. As of July 31, 2024 and January 31, 2024, there was no unrecognized compensation cost related to these shares. During the three and six months ended July 31, 2023, the Company recognized $0.6 million and $1.3 million of stock-based compensation expense related to these shares, respectively.

(13) Income Taxes
During the three and six months ended July 31, 2024, the Company recorded income tax expense of $0.9 million and $1.3 million, respectively. During the three and six months ended July 31, 2023, the Company recorded income tax expense of $0.6 million and $0.9 million, respectively. For the three and six months ended July 31, 2024 and 2023, the income tax expense was primarily driven by the current tax on foreign earnings. The effective tax rates for the three and six months ended July 31, 2024 and 2023 differed from the federal statutory tax rate primarily due to the valuation allowance on the majority of the Company’s U.S. and foreign deferred tax assets and foreign rate differences.
The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. Gross unrecognized tax benefits were $9.4 million and $8.7 million as of July 31, 2024 and January 31, 2024, respectively. The gross unrecognized tax benefits, if recognized, would not affect the effective tax rate due to the valuation allowance against the deferred tax assets. The Company determined that no accrual for interest and penalties was required as of July 31, 2024 and January 31, 2024 and no such expenses were incurred in the periods presented.
The Company does not anticipate the total amounts of unrecognized tax benefits to significantly increase or decrease in the next twelve months.
The Company files U.S. federal, various state and foreign income tax returns. The Company is not currently under audit by any taxing authorities. All tax years remain open to examination by taxing jurisdictions to which the Company is subject.

26

(14)Net Loss Per Share Attributable to Common Stockholders
The Company computes net loss per share of the Class A common stock and Class B common stock using the two-class method required for participating securities. Basic and diluted net loss per share are the same for each class of common stock because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per Class A common stock and Class B common stock (amounts in thousands, except share and per share amounts):
 Three Months Ended July 31,Six Months Ended July 31,
 2024202320242023
Numerator:
Net loss attributable to common stockholders$(38,668)$(37,975)$(67,961)$(72,419)
Denominator:
Basic and diluted weighted-average common shares outstanding used in computing net loss per share attributable to common stockholders290,364,319275,053,198289,328,033273,723,006
       Basic and diluted net loss per share attributable to common stockholders$